Georgia commission might vote this week on medical cannabis rules
Marijuana Industry NewsMedical Marijuana January 24, 2023 MJ Shareholders 0
Georgia’s long-delayed medical marijuana program is about to take off, despite a spate of unresolved lawsuits from companies that lost out in the bidding for licenses.
The Georgia Access to Medical Cannabis Commission is expected to vote Wednesday on rules governing all aspects of the program from growing the leaf crop in greenhouses under close supervision to manufacturing low-THC cannabis oil to treat patients suffering from a variety of diseases to selling the product at a network of dispensaries across the state.
“We’ll have a big ramp-up,” said Andrew Turnage, the commission’s executive director.
The commission voted in September to award the first two of six production licenses authorized in a law the General Assembly passed in 2019.
Executives with Trulieve Georgia and Botanical Sciences LLC endorsed the proposed rules during a public hearing Aug. 18 and said they’re ready to go. Trulieve is building a production facility in Adel, while Botanical Sciences will set up shop in Glennville.
“No time should be wasted approving these rules,” Trulieve President Lisa Pinkney told the commission. “We look forward to making a difference for patients in this state.”
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.